Display options
Cite
Zheng L, Luo M, Kuang G, et al. Capsular Polysaccharide From . Front Pharmacol. 2020;11:570476doi: 10.3389/fphar.2020.570476.
Zheng, L., Luo, M., Kuang, G., Liu, Y., Liang, D., Huang, H., Yi, X., Wang, C., Wang, Y., Xie, Q., & Zhi, F. (2020). Capsular Polysaccharide From . Frontiers in pharmacology, 11570476. https://doi.org/10.3389/fphar.2020.570476
Zheng, Lijun, et al. "Capsular Polysaccharide From ." Frontiers in pharmacology vol. 11 (2020): 570476. doi: https://doi.org/10.3389/fphar.2020.570476
Zheng L, Luo M, Kuang G, Liu Y, Liang D, Huang H, Yi X, Wang C, Wang Y, Xie Q, Zhi F. Capsular Polysaccharide From . Front Pharmacol. 2020 Dec 07;11:570476. doi: 10.3389/fphar.2020.570476. eCollection 2020. PMID: 33364945; PMCID: PMC7751226.
Copy Download .nbib Format: NLM
Share it on

Front Pharmacol. 2020 Dec 07;11:570476. doi: 10.3389/fphar.2020.570476. eCollection 2020.

Capsular Polysaccharide From .

Frontiers in pharmacology

Lijun Zheng, Meihua Luo, Gaobo Kuang, Yangyang Liu, Debao Liang, Haiqing Huang, Xiaomin Yi, Congfeng Wang, Ye Wang, Qiuling Xie, Fachao Zhi

Affiliations

  1. College of Life Science and Technology, Jinan University, Guangzhou, China.
  2. Guangzhou ZhiYi Biotechnology Co. Ltd., Guangzhou, China.
  3. Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

PMID: 33364945 PMCID: PMC7751226 DOI: 10.3389/fphar.2020.570476

Abstract

The prominent human symbiont

Copyright © 2020 Zheng, Luo, Kuang, Liu, Liang, Huang, Yi, Wang, Wang, Xie and Zhi.

Keywords: Bacteroides fragilis; capsular polysaccharide; fluorescently-labeled TP2; pharmacokinetic; ulcerative colitis

Conflict of interest statement

LZ, GK, YL, DL, HH, XY, CW, and YW were employed by Guangzhou ZhiYi Biotechnology Co. Ltd. The property of B. fragilis ZY-312 and polysaccharide TP2 belongs to Guangzhou ZhiYi Biotechnology Co. Ltd. A

References

  1. Dis Colon Rectum. 2006 Feb;49(2):250-8 - PubMed
  2. Front Microbiol. 2017 Mar 17;8:435 - PubMed
  3. Gastroenterology. 2019 Feb;156(3):748-764 - PubMed
  4. Mucosal Immunol. 2010 Sep;3(5):487-95 - PubMed
  5. Oral Dis. 2002 May;8(3):117-29 - PubMed
  6. Expert Opin Emerg Drugs. 2009 Sep;14(3):505-21 - PubMed
  7. Cell Host Microbe. 2016 Oct 12;20(4):535-547 - PubMed
  8. Glycobiology. 2015 Apr;25(4):368-75 - PubMed
  9. Dig Dis Sci. 2011 Mar;56(3):707-14 - PubMed
  10. Lancet. 2018 Dec 23;390(10114):2769-2778 - PubMed
  11. Food Res Int. 2017 Oct;100(Pt 3):404-410 - PubMed
  12. Front Immunol. 2018 May 09;9:1040 - PubMed
  13. Trends Biotechnol. 2015 Sep;33(9):496-503 - PubMed
  14. Front Microbiol. 2018 Oct 01;9:2298 - PubMed
  15. Front Microbiol. 2018 Dec 21;9:2976 - PubMed
  16. Int Immunopharmacol. 2013 Jan;15(1):23-9 - PubMed
  17. Crit Rev Food Sci Nutr. 2017 Sep 22;57(14):2943-2955 - PubMed
  18. Food Res Int. 2018 Jan;103:280-288 - PubMed
  19. Nature. 2016 Dec 21;540(7634):S98-S99 - PubMed
  20. Curr Opin Microbiol. 2017 Feb;35:8-15 - PubMed
  21. Gut Microbes. 2015 Jul 4;6(4):234-42 - PubMed
  22. Biochem Pharmacol. 1993 Mar 24;45(6):1215-26 - PubMed
  23. Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12204-9 - PubMed
  24. Int J Pharm. 2004 Nov 22;286(1-2):9-17 - PubMed
  25. Nature. 2008 May 29;453(7195):620-5 - PubMed
  26. mSystems. 2019 Aug 6;4(4): - PubMed
  27. Sci Rep. 2016 Jul 06;6:29401 - PubMed
  28. Front Cell Infect Microbiol. 2017 May 11;7:170 - PubMed
  29. J Agric Food Chem. 2019 May 29;67(21):5968-5977 - PubMed
  30. Nat Rev Immunol. 2006 Nov;6(11):849-58 - PubMed
  31. Nat Rev Microbiol. 2008 Feb;6(2):121-31 - PubMed
  32. PLoS One. 2017 Jul 6;12(7):e0180025 - PubMed

Publication Types